We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Alcohol Overuse Is Often Undiagnosed in HIV-Infected Persons

By LabMedica International staff writers
Posted on 28 Jun 2011
Scientists evaluated the ability of the carbohydrate-deficient transferrin (CDT) biomarker to detect unhealthy alcohol consumption among people infected with Human immunodeficiency virus (HIV).

Although CDT, often measured as %CDT, can detect very heavy drinking, whether it does so in people with HIV in a clinically useful manner has yet to be established.

Investigators at the Boston University School of Medicine (BUSM; MA, USA) and colleagues evaluated the ability of %CDT and gamma glutamyltransferase to detect three levels of unhealthy alcohol consumption: at-risk, heavy, and frequent heavy drinking as determined by a reference standard questionnaire.

Of 300 subjects, 103 reported current consumption at at-risk amounts, and 47 reported heavy amounts. For at-risk drinking, sensitivity of %CDT was 28 %, meaning the test detected only 28 % of those with unhealthy alcohol use. For heavy drinking, sensitivity was 36 %. According to the scientists, these findings suggest that %CDT is not sufficiently sensitive for use in screening for unhealthy alcohol use by people with HIV infection.

"There is evidence that early intervention for unhealthy alcohol use can be effective but early clinical signs are often missed and unhealthy alcohol use often goes undiagnosed by HIV healthcare providers," explained principal investigator Jeffrey Samet, MD, MA, MPH, professor of medicine at BUSM. "Unfortunately among HIV-infected adults with alcohol problems, %CDT had poor overall accuracy for detecting unhealthy drinking," he added.

Alcohol use is common in HIV-infected persons. It can interfere with HIV medication adherence, lower CD4 cell count, and even cause hepatic injury. Furthermore, HIV coinfection with viral hepatitis is common and both HIV and viral hepatitis are adversely impacted by alcohol. For these reasons, detection of unhealthy alcohol use is important in the clinical care of HIV-infected individuals.

Related Links:
Boston University School of Medicine





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Electrolyte Analyzer
BKE-B

Latest Clinical Chem. News

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes
28 Jun 2011  |   Clinical Chem.

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care
28 Jun 2011  |   Clinical Chem.

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection
28 Jun 2011  |   Clinical Chem.